Top

Published in:

01-12-2014 | Original Paper

Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition

Authors: Ana Agusti, Jennifer L. Dziedzic, Vicente Hernandez-Rabaza, Tomas R. Guilarte, Vicente Felipo

Published in: Metabolic Brain Disease | Issue 4/2014

Abstract

Neuroinflammation plays a main role in neurological deficits in rats with minimal hepatic encephalopathy (MHE) due to portacaval shunt (PCS). Treating PCS rats with SB239063, an inhibitor of MAP-kinase-p38, reduces microglial activation and brain inflammatory markers and restores cognitive and motor function. The translocator protein-(18-kDa) (TSPO) is considered a biomarker of neuroinflammation. TSPO is increased in brain of PCS rats and of cirrhotic patients that died in hepatic coma. Rats with MHE show strong microglial activation in cerebellum and milder in other areas when assessed by MHC-II immunohistochemistry. This work aims were assessing: 1) whether binding of TSPO ligands is selectively increased in cerebellum in PCS rats; 2) whether treatment with SB239063 reduces binding of TSPO ligands in PCS rats; 3) which cell type (microglia, astrocytes) increases TSPO expression. Quantitative autoradiography was used to assess TSPO-selective ³H-(R)-PK11195 binding to different brain areas. TSPO expression increased differentially in PCS rats, reaching mild expression in striatum or thalamus and very high levels in cerebellum. TSPO was expressed in astrocytes and microglia. Treatment with SB239063 did not reduces ³[H]-PK11195 binding in PCS rats. SB239063 reduces microglial activation and levels of inflammatory markers, but not binding of TSPO ligands. This indicates that SB239063-induced neuroinflammation reduction in PCS rats is not mediated by effects on TSPO. Also, enhanced TSPO expression is not always associated with cognitive or motor deficits. If enhanced TSPO expression plays a role in mechanisms leading to neurological alterations in MHE, SB239063 would interfere these mechanisms at a later step.

Available only for authorised users

Agusti A, Cauli O, Rodrigo R, Llansola M, Hernandez-Rabaza V, Felipo V (2011) p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 60:1572–1579PubMedCrossRef

Ahboucha S, Butterworth RF (2007) The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab Brain Dis 22(3–4):291–308PubMedCrossRef

Ahboucha S, Butterworth RF (2008) The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 52(4–5):575–587PubMedCrossRef

Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF (2006) Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem Int 49:372–378PubMedCrossRef

Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253–267PubMedCrossRef

Banati R (2002) Visualising microglial activation in vivo. Glia 40:206–217PubMedCrossRef

Bodega G, Suárez I, Arilla E, Rubio M, Fernández B (1991) Heterogeneous astroglial response in the rat spinal cord to long-term portacaval shunt: an immunohistochemical study. Glia 4:400–407PubMedCrossRef

Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT (2009) Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 29:783–788PubMedCrossRef

Cagnin A, Taylor-Robinson SD, Forton MD, Banati RB (2006) In vivo imaging of cerebral “peripheral benzodiazepine binding sites” in patients with hepatic encephalopathy. Gut 55:547–553PubMedCentralPubMedCrossRef

Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V (2007) Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46:514–519PubMedCrossRef

Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V (2009a) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24(1):69–80PubMedCrossRef

Cauli O, Mansouri MT, Agusti A, Felipo V (2009b) Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136:1359–1367PubMedCrossRef

Chen MK, Guilarte TR (2006) Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicol Sci 91:532–539PubMedCrossRef

Chen MK, Guilarte TR (2008) Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 118:1–17PubMedCentralPubMedCrossRef

Chen MK, Baidoo K, Verina T, Guilarte TR (2004) Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain Res Mol Brain Res 127:1379–1392

Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Peranzi G, Yao ZX, Maccario J, Lacapere JJ, Papadopoulos V (2003) In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42:4506–4519PubMedCrossRef

Desjardins P, Butterworth RF (2002) The “peripheral-type” benzodiazepine(omega 3) receptor in hyperammonemic disorders. Neurochem Int 41:109–114PubMedCrossRef

Desjardins P, Bandeira P, Raghavendra Rao VL, Ledoux S, Butterworth RF (1997) Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis. Brain Res Brain Res Rev 758(1–2):255–258

Diemer NH, Laursen H (1977) Glial cell reactions in rats with hyperammoniemia induced by urease or porto-caval anastomosis. Acta Neurol Scand 55:425–442PubMedCrossRef

Diemer NH, Klee J, Schröder H, Klinken L (1977) Glial and nerve cell changes in rats with porto-caval anastomosis. Acta Neuropathol 39:59–68PubMedCrossRef

Ducis I, Norenberg NL, Norenberg MD (1989) Effect of ammonium chloride on the astrocyte benzodiazepine receptor. Brain Res 493(2):362–5PubMedCrossRef

Felipo V, Ordoño JF, Urios A, El Mlili N, Giménez-Garzó C, Aguado C, González-Lopez O, Giner-Duran R, Serra MA, Wassel A, Rodrigo JM, Salazar J, Montoliu C (2012) Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 55(2):530–9PubMedCrossRef

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy. Definition, nomenclature, diagnosis and quantification: final report of the working party at the 11Word congress gastroenterology, Vienna, 1998. Hepatology 35:716–721PubMedCrossRef

Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, Winston A (2013) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART; An 11C-PK11195 PET study. AIDS, 2013 Jul 24

Giguère JF, Hamel E, Butterworth RF (1992) Increased densities of binding sites for the “peripheral-type” benzodiazepine receptor ligand [3H]PK11195 in rat brain following portacaval anastomosis. Brain Res 585:295–298PubMedCrossRef

González-Usano A, Cauli O, Agustí A, Felipo V (2013) Hyperamonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA- or sigma receptors in cerebellum in vivo. J Neurochem 125(1):133–43PubMedCrossRef

Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC et al (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49PubMedCrossRef

Guilarte TR, Kuhlmann AC, O’Callaghan JP, Miceli RC (1995) Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. Neurotoxicology 16(3):441–50PubMed

Guilarte TR, Nihei MK, McGlothan JL, Howard AS (2003) Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 122(2):499–513PubMedCrossRef

Itzhak Y, Norenberg M (1994) Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci Lett 182(2):251–4PubMedCrossRef

Jayakumar AR, Panickar KS, Norenberg MD (2002) Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells. J Neurochem 83:1226–1234PubMedCrossRef

Jorda EG, Jimenez A, Verdaguer E, Canudas AM, Folch J, Sureda FX, Camins A, Pallas M (2005) Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis. Apoptosis 10:91–104PubMedCrossRef

Kuhlmann AC, Guilarte TR (1997) The peripheral benzodiazepine receptor is a sensitive indicator of domoic acid neurotoxicity. Brain Res 751:281–288PubMedCrossRef

Kuhlmann AC, Guilarte TR (1999) Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity. Toxicol Sci 48:107–116PubMedCrossRef

Kuhlmann AC, Guilarte T (2000) Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 74(4):1694–704PubMedCrossRef

Laursen H, Diemer NH (1980) Morphometry of astrocyte and oligodendrocyte ultrastructure after portocaval anastomosis in the rat. Acta Neuropathol 51:65–70PubMedCrossRef

Lavoie J, Layrargues GP, Butterworth RF (1990) Increased densities of peripheral-type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy. Hepatology 11(5):874–878PubMedCrossRef

Lee SH, Fisher B (1961) Portacaval shunt in the rat. Surgery 50:668–672PubMed

Ma KC, Chang ZH, Shih H, Zhu JH, Wu JY (1991) The compensatory ‘rebound’ of reactive astrogliosis: glial fibrillary acidic protein immunohistochemical analysis of reactive astrogliosis after a puncture wound to the brain of rats with portocaval anastomosis. Acta Neuropathol 82:72–77PubMedCrossRef

Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, Okauchi T, Zhang MR, Suzuki K, Suhara T (2007) Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res Mol 1157:100–111CrossRef

Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM et al (2007) Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med 85:233–241CrossRef

Montoliu C, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V (2009) IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43(3):272–279PubMedCrossRef

Myers R, Manjil LG, Cullen BM, Price GW, Frackowiak RS, Cremer JE (1991) Macrophage and astrocyte populations in relation to [3H]PK11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11:314–322PubMedCrossRef

Odeh M, Sabo E, Srugo I, Oliven A (2004) Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int 24(2):110–116PubMedCrossRef

Odeh M, Sabo E, Srugo I, Oliven A (2005) Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann Med 37:603–612PubMedCrossRef

Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, Hardwick M, Li H, Vidic B, Brown AS, Reversa JL, Bernassau JM, Drieu K (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62(1):21–8PubMedCrossRef

Pilbeam CM, Anderson RM, Bhathal PS (1983) The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models. J Pathol 140:331–345PubMedCrossRef

Raghavendra Rao VL, Audet R, Therrien G, Butterworth RF (1994) Tissue specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]-PK11195 in rats following portacaval anastomosis. Dig Dis Sci 39:1055–1063CrossRef

Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139(2):675–684PubMedCrossRef

Rojas S, Martín A, Arranz MJ, Pareto D, Purroy J, Verdaguer E, Llop J et al (2007) Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab 27:1975–1986PubMedCrossRef

Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J (2001) Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96:2718–2723PubMedCrossRef

Shawcross DL, Davies N, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40:247–254PubMedCrossRef

Stephenson DT, Schober D, Smalstig EB, Mincy RE, Gehlert DR, Clemens (1995) Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci Res 15:5263–5274

Suárez I, Bodega G, Arilla E, Rubio M, Villalba R, Fernández B (1992) Different response of astrocytes and Bergmann glial cells to portacaval shunt: an immunohistochemical study in the rat cerebellum. Glia 6:172–179PubMedCrossRef

Suárez I, Bodega G, Arilla E, Fernández B (1997) Region-selective glutamine synthetase expression in the rat central nervous system following portocaval anastomosis. Neuropathol Appl Neurobiol 23:254–261PubMedCrossRef

Suárez I, Bodega G, Rubio M, Fernández B (2005) Down-regulation of astroglial proteins in the rat cerebellum after portacaval anastomosis. Neuropathol Appl Neurobiol 31:163–169PubMedCrossRef

Veiga S, Azcoitia I, Garcia-Segura LM (2005) Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J Neurosci Res 80:129–137PubMedCrossRef

Veiga S, Carrero P, Pernia O, Azcoitia I, Garcia-Segura LM (2007) Translocator protein 18 kDa is involved in the regulation of reactive gliosis. Glia 55:1426–1436PubMedCrossRef

Title: Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition
Authors: Ana Agusti
Jennifer L. Dziedzic
Vicente Hernandez-Rabaza
Tomas R. Guilarte
Vicente Felipo
Publication date: 01-12-2014
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 4/2014
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-013-9461-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes

Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats

Assessing inter- and intra-individual cognitive variability in patients at risk for cognitive impairment: the case of minimal hepatic encephalopathy

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liver-brain axis

Role of astrocytes in thiamine deficiency

Elevated cerebral lactate: Implications in the pathogenesis of hepatic encephalopathy